| Patient | Ernest Shackleton |
|---|---|
| Date of birth | 1979-02-15 |
| Identifiers | MRN HR-EX001-SYN; SSN (made up) 000-01-7763 |
| Document date | 2026-08-11 |
| Author | Cormac Ellingsworth-Daly, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit before a long expedition. [S]
Mr. Shackleton is a 47-year-old expedition leader with chronic coronary disease, a drug-eluting stent in the proximal left anterior descending artery placed six weeks ago, nicotine dependence in early remission, hyperlipidemia, and prediabetes, who comes for a preventive visit about five weeks before his expedition sails. He has had no chest pain since the stent and is going to cardiac rehabilitation three times a week. He has not smoked for almost three months and still takes varenicline. He drinks two drinks at most on four evenings a week. He takes aspirin, clopidogrel, atorvastatin, ezetimibe, and metoprolol every day and carries nitroglycerin, which he has not needed since the procedure. He wants to leave with his prevention up to date and his affairs in order. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 47 |
| Heart | No angina since the stent; rehabilitation three times a week |
| Tobacco | Not smoked for almost three months; on varenicline |
| Alcohol | Two drinks at most on four evenings a week |
| Mood | PHQ-2 0 |
Health risk assessment. Completed by the patient on paper in the waiting room and reviewed with him face to face by Dr. Ellingsworth-Daly. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Very good, better than for years |
| Psychosocial | Under heavy pressure with the ship and the budget, but sleeping and coping |
| Tobacco | Not smoked for almost three months; craving now rare |
| Alcohol | Within the limits agreed in May |
| Physical activity | Cardiac rehabilitation three times a week and brisk walks |
| Nutrition | Less red meat, more fish and vegetables; less salt |
| Sleep | Six hours on most nights |
| Sexual health | Married, one partner; no concerns |
| Safety at work | Heavy lifting at the dock; now delegates most of it |
| Road safety | Wears a seat belt; drives within the city |
| Activities of daily living | Independent |
| Hearing and vision | Reading glasses; hearing normal |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, weight loss, or night sweats; weight down 2 kg since May |
| Eyes | Negative | No vision change apart from needing reading glasses |
| Ears, nose, mouth, and throat | Negative | No hearing change, sore throat, or dental pain |
| Cardiovascular | Negative | No chest pain, palpitations, fainting, or ankle swelling |
| Respiratory | Positive | Less morning cough since stopping smoking; no breathlessness on the rehabilitation program |
| Gastrointestinal | Negative | No heartburn, black stools, or rectal bleeding |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Negative | No muscle aches on the statin; no joint pain |
| Integumentary | Negative | Small bruise at the wrist puncture site has gone; no easy bruising |
| Neurological | Negative | No weakness, numbness, or headaches |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-12 | active | S |
| Atorvastatin 80 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-12 | active | S |
| Metoprolol succinate extended-release 50 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-12 to 2026-05-26 | stopped | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeat every 5 minutes up to 3 doses | as needed for chest pain, up to 3 doses | Sublingual route | 2026-05-12 | active | S |
| Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration | twice a day after titration | Oral route | 2026-05-12 | active | S |
| Metoprolol succinate extended-release 100 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-05-26 | active | S |
| Clopidogrel 75 mg tablet, one tablet by mouth daily for six months after the stent (600 mg loading dose before the procedure) | once daily for six months | Oral route | 2026-07-01 | active | S |
| Ezetimibe 10 mg tablet, one tablet by mouth daily | once daily | Oral route | 2026-07-21 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-11 | Body height | 175 | cm | S |
| 2026-08-11 | Body weight | 83.8 | kg | S |
| 2026-08-11 | Body mass index (BMI) [Ratio] | 27.4 | kg/m2 | S |
| 2026-08-11 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-08-11 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-08-11 | Heart rate | 60 | /min | S |
| 2026-08-11 | Respiratory rate | 14 | /min | S |
| 2026-08-11 | Body temperature | 36.6 | Cel | S |
| 2026-08-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-11 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
Vital signs recorded on 2026-08-11; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 83.8 kg, BMI 27.4; blood pressure 122/76, pulse 60 |
| Mouth | Teeth in fair repair; no gum disease |
| Neck | No carotid bruits; no lymph node enlargement |
| Cardiovascular | Regular rhythm; normal heart sounds; no murmur; right radial pulse normal at the access site |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no aortic pulsation felt |
| Skin | Weathered, sun-damaged skin on the face and hands; no suspicious lesions |
| Extremities | No edema; foot pulses normal |
| Musculoskeletal | Normal range of movement |
| Psychiatric | Cheerful, energetic, and engaged |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chest tightness and breathlessness on exertion for about three months, brought on by stairs, carrying loads, and walking fast in cold wind and relieved within minutes by rest, never at rest; resting ECG normal; cause not yet established at intake; coronary CT angiography and cardiology consultation requested | resolved | confirmed | R07.89 | S — Synthetic presenting problem anchored to his documented exertional breathlessness; superseded by the diagnosis at the cardiology consultation. |
| Nicotine dependence, cigarettes: about 25 a day since 16 (about 39 pack-years) | active | confirmed | F17.210 | S — Synthetic modern coding anchored to his documented heavy smoking. |
| Chronic coronary disease with stable exertional angina: 80% stenosis of the proximal left anterior descending artery with CT-FFR 0.70, mild right coronary artery disease, coronary calcium score 210, and normal left ventricular function; synthetic modern episode linked to his documented exertional illnesses and the coronary atheroma recorded at his death | active | confirmed | I25.118 | S — Synthetic modern diagnosis made at the cardiology consultation; Macklin's coronary diagnosis is recorded in CLM-0009 and the alternative theories as R. |
| Hyperlipidemia: LDL cholesterol 168 mg/dL and HDL 38 mg/dL at intake | active | confirmed | E78.5 | S — Synthetic modern risk factor; no historical measurement exists. |
| Prediabetes: HbA1c 5.9% at intake | active | confirmed | R73.03 | S — Synthetic modern risk factor; no historical measurement exists. |
| Drug-eluting stent in the proximal left anterior descending artery, placed for angina that persisted on medical therapy; dual antiplatelet therapy for six months | active | confirmed | Z95.5 | S — Synthetic status after the modern procedure. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 122/76 mmHg on metoprolol |
| Depression screening | Completed today | PHQ-2 score 0 |
| Tobacco cessation | Completed today | Abstinent for almost three months on varenicline; relapse prevention for the voyage discussed: no cigarettes in his kit, and support by satellite message |
| Unhealthy alcohol use | Up to date | AUDIT 12 at intake with a brief intervention; AUDIT-C 4 three weeks ago; drinking within the agreed limit by his report |
| Colorectal cancer screening | Ordered | Due from 45; fecal immunochemical test kit given, to be returned before he sails; colonoscopy deferred while he is on dual antiplatelet therapy |
| Lung cancer screening | Not indicated | Begins at 50 for adults with 20 or more pack-years who smoke or quit within 15 years; he will qualify at 50 |
| HIV screening | Ordered | One-time screening for adults 15 to 65; drawn today with his agreement |
| Hepatitis C screening | Ordered | One-time antibody test for adults 18 to 79, drawn today |
| Hepatitis B screening | Ordered | One-time triple panel drawn today; vaccination to follow if he is not immune |
| Diabetes | Up to date | Prediabetes (HbA1c 5.9% at intake); repeat HbA1c at the pre-departure visit |
| Cholesterol | Up to date | LDL cholesterol 62 mg/dL three weeks ago; ezetimibe added; repeat at the pre-departure visit |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap given today; no dose recorded in the last ten years |
| Pneumococcal vaccine | Completed today | PCV20 given today for cigarette smoking and chronic coronary disease; no further pneumococcal dose needed |
| Influenza vaccine, this season | Due | At the pre-departure visit, once this season's vaccine arrives |
| COVID-19 vaccine, this season | Declined | Discussed; he chose not to have it before sailing |
| Travel vaccines and advice | Referred | Travel medicine clinic for the ports on the route, including yellow fever, hepatitis A, and typhoid vaccines as indicated |
| Skin cancer counseling and dental care | Completed today | Sun and snow-glare protection discussed; dental check booked before departure |
Immunizations given today: Tdap vaccine; Pneumococcal conjugate vaccine (PCV20) [S]
Guideline basis: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (Virani SS, et al. Circulation 2023;148(9):e9-e119) (2023); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Medical Condition and Other Indication (2026)
Follow-up: Pre-departure review in four weeks with an exercise test, lipids, HbA1c, and the influenza vaccine. Screening results through the patient portal. Travel medicine this week. Next scheduled visit 2026-09-08: four-month review before departure: exercise test, lipids, HbA1c, and the expedition medical plan. [S]
Voluntary advance care planning discussion of about 20 minutes, with his consent, because he will be weeks from a hospital. He named a health care agent and a second agent, and a health care proxy form was completed; both are recorded in the chart and are not named here. He wants full treatment, including resuscitation, if he becomes ill at sea, treatment aboard first with evacuation when it is possible, and he wants the expedition to continue if he cannot. He asked that a copy travel with his cardiac summary. The plan will be revisited on his return or after any serious illness. [S]